Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 43 - Drugs for specific purposes, not provided for in groups
Patents for A61P 43 - Drugs for specific purposes, not provided for in groups (156,317)
11/1995
11/02/1995EP0679631A1 Biaromatic acetylated, an adamantyl group containing compounds, pharmaceutical and cosmetic compositions containing them and their use
11/02/1995EP0679628A1 Polyene derivatives, pharmaceutical and cosmetic composition containing them and their use
11/02/1995EP0679393A2 Pharmaceutical composition for treating osteoporosis containing xanthohumol
11/02/1995EP0679185A1 Ras associated gap proteins
11/02/1995EP0679161A1 Thiazolidine derivatives, preparation thereof and drugs containing same
11/02/1995EP0679160A1 Pyrimidine nucleotide precursors for treatment of systemic inflammation and inflammatory hepatitis
11/02/1995EP0679157A1 Novel 3,4-diaryl thiophenes and analogs thereof having use as antiinflammatory agents
11/02/1995EP0679097A1 Tgf-beta formulation for inducing bone growth.
11/02/1995EP0679092A1 Cytokine restraining agents
11/02/1995EP0679090A1 Method for treating myofascial pain syndrome
11/02/1995EP0679089A1 Methods for promoting cartilage matrix formation
11/02/1995EP0679088A1 Pulmonary delivery of active fragments of parathyroid hormone
11/02/1995EP0561766B1 Use of essential fatty acids for the preparation of a drug for the treatment of eczema
11/02/1995CA2188748A1 Benzocycloalkylazolethione derivatives
11/02/1995CA2188031A1 Spiro-substituted azacycles as neurokinin-3 antagonists
11/02/1995CA2187459A1 Permeabilizer peptides for increasing blood-ocular barrier permeability
11/01/1995CN1110968A Substituted N-piperidino-pyrazole-3-carboxamide
11/01/1995CN1110915A Method for prepn. of cerebral proteolytic liquid-cerebral health injection
10/1995
10/31/1995US5463107 Useful in prophylaxis and treatment of diseases caused by excessive secretion of endothelin
10/31/1995US5463083 2,5-diaryl tetrahydrothiophenes, tetrahydrofurans and 1,3-diaryl-cyclopentanes which act as platelet activating factor receptor antagonists and/or inhibitors of the enzyme 5-lipoxygenase
10/31/1995US5463071 Tetrazole derivatives; useful for inhibiting undesirable cell aggregation
10/31/1995US5463063 Preparation of thalidomide; inhibitor of tumor necrosis factor
10/31/1995US5462976 Photocurable glycosaminoglycan derivatives, crosslinked glycosaminoglycans and method of production thereof
10/31/1995US5462968 EP2 -receptor agonists as agents for lowering intraocular pressure
10/31/1995US5462960 Very good affinity for cannabinoid receptor; having psycho-tropic activity
10/31/1995US5462959 4-aryl-imidazole derivatives
10/31/1995US5462957 Azole derivatives, pharmaceutical compositions containing the same, and method for treating mycosis and estrogen-dependent diseases
10/31/1995US5462951 Dissolved in a polyoxyethylene sorbitan fatty acid ester and adsorbed onto a porosity inorganic substance
10/31/1995US5462950 Administering raloxifene or salt
10/31/1995US5462947 Nervous system disorders
10/31/1995US5462946 Metal-independent nitroxide or oxazolidine-1-oxyl forming compound in biologically acceptable carrier to protect biological material from oxidative stress
10/31/1995US5462942 2,3-dihydro-1,4-benzodioxin-5-yl-piperazine derivatives having 5-HT 1A-antagonistic activity
10/31/1995US5462939 Treating infectious diseases, septic shock, respiratory diseases, inflammatory conditions, autoimmune diseases, bone diseases
10/31/1995US5462933 Modified bile acid conjugates, and their use as pharmaceuticals
10/31/1995US5462932 Aqueous, buffered alendronate solution containing a complexing agent to prevent precipitation; bone loss prevention
10/31/1995US5462926 Inhibiting inositol phosphate by contacting cells with an octapeptide
10/31/1995US5462925 Transforming growth factor β2,3
10/31/1995CA2042398C Orally administered porphyrins to control intestinal iron absorption
10/30/1995CA2148053A1 Non-peptidyl tachykinin receptor antagonists
10/26/1995WO1995028484A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995WO1995028480A1 Methods of use of uncoated gel particles
10/26/1995WO1995028474A1 Dna encoding bradykinin b1 receptor
10/26/1995WO1995028426A2 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995WO1995028422A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995WO1995028401A1 Tropane-2-aldoxine derivatives as neurotransmitter reuptake inhibitors
10/26/1995WO1995028399A1 A method of inducing cholecystokinin agonist activity using 1,4-benzodiazepine compounds
10/26/1995WO1995028397A1 Alpha1c adrenergic receptor antagonists
10/26/1995WO1995028386A1 Substituted pyridine leukotriene b4 antagonists
10/26/1995WO1995028376A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/26/1995WO1995028172A1 Human bone stimulating factor
10/26/1995WO1995028170A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995WO1995028163A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995WO1995028162A1 Ameliorant or remedy for paraneoplastic syndrome
10/26/1995WO1995028157A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995WO1995028151A1 Use of maillard reaction inhibitors for the treatment of amyloidosis-based disease
10/26/1995DE4447484A1 APO-1 inhibitor compsn. inhibits apoptosis
10/26/1995DE4410997A1 Pharmazeutische Zubereitungen und Arzneistoffe zur Prävention und Behandlung endothelialer Dysfunktionen Pharmaceutical drugs for the prevention and treatment of endothelial dysfunction
10/26/1995CA2189028A1 Hek5, hek7, hek8, hek11, new eph-like receptor protein tyrosine kinases
10/26/1995CA2188287A1 Icam-1/lfa-1 short-chain peptides and method of using same
10/26/1995CA2188180A1 Methods of producing effective recombinant serine protease inhibitors and uses of these inhibitors
10/26/1995CA2188172A1 Human bone stimulating factor
10/26/1995CA2187791A1 Inhibitors of influenza virus neuraminidase and methods of making and using the same
10/26/1995CA2187773A1 Use of alpha-1c specific compounds to treat benign prostatic hyperplasia
10/26/1995CA2187767A1 Alpha1c adrenergic receptor antagonists
10/26/1995CA2187642A1 Peptides for reducing or inhibiting bone resorption, angiogenesis and restenosis
10/26/1995CA2187526A1 Methods of use of uncoated gel particles
10/26/1995CA2186738A1 Enteral formulations for the treatment of inflammation and infection containing a saponin, possibly in combination with other compounds
10/26/1995CA2186252A1 Substituted pyridine leukotriene b4 antagonists
10/25/1995EP0678503A1 Delta-amino-gamma-hydroxy-omega-aryl alkanoic acid amides with enzyme especially renin inhibiting activities
10/25/1995EP0678101A1 Growth differentiation factor-9
10/25/1995EP0678098A1 Pyrrolidine and thiazolidine derivatives, their preparation and drugs containing same
10/25/1995EP0678090A1 Piperazine derivatives
10/25/1995EP0678087A1 Compounds having selective activity for retinoid x receptors, and means for modulation of processes mediated by retinoid x receptors
10/25/1995EP0678086A1 Compounds having selectivity for retinoid x receptors
10/25/1995EP0678031A1 Tissue-derived tumor growth inhibitors, methods of preparation and uses thereof
10/25/1995EP0678022A1 Application of riluzole as a radiorestorer.
10/25/1995EP0678021A1 Methods for the improvement of cognition with functional antagonists of the glycine nmda receptor complex
10/25/1995EP0678020A1 Compositions comprising cholesterol lowering agents and antioxidants
10/25/1995CN1110575A Medical liquid and its preparation method
10/24/1995US5461146 Enzyme inhibitor protecting nerve cells from degeneration
10/24/1995US5461067 For HIV infections
10/24/1995US5461061 Antidepressants
10/24/1995US5461059 Derivatives of terbutylphenyl-1-amino-4-hydroxybutane their preparation processes and the pharmaceutical compositions containing them
10/24/1995US5461054 Anthracene-spiro-pyrrolindines
10/24/1995US5461047 2-,3-,4-,5-,6-,7-,8-,9- and/or 10-substituted dibenzoxazepine and dibenzthiazepine compounds, pharmaceutical compositions and methods of use
10/24/1995US5461035 Short peptides with insulin activity
10/24/1995US5461030 Compositions and methods for enhancing wound healing
10/24/1995US5460951 Bone-related carboxypeptidase-like protein and process for its production
10/24/1995US5460820 Methods for providing testosterone and optionally estrogen replacement therapy to women
10/24/1995US5460810 Method for maintaining gut epithelial cells by treatment with a cytokine such as interleukin 11
10/24/1995US5460807 Polyurea or polyamide oligomers useful for inhibiting smooth muscle cells
10/24/1995CA2015585C Method and compositions for treatment of mast cell-mediated dermatologic disorders
10/24/1995CA1337415C Indole derivatives
10/22/1995CA2147419A1 Pharmaceutical composition for treating osteoporosis
10/21/1995CA2147429A1 Piperidine derivatives and anti-platelet agents containing the same
10/19/1995WO1995027793A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE II (ICErel-II)
10/19/1995WO1995027792A1 DNA ENCODING PRECURSOR OF INTERLEUKIN-1β CONVERTING ENZYME-RELATED CYSTEINE PROTEINASE III (ICErel-III)
10/19/1995WO1995027781A1 Superoxide dismutase-4
10/19/1995WO1995027735A1 Apoptose inhibitor
10/19/1995WO1995027723A1 Receptor modulating agents and methods relating thereto
1 ... 1390 1391 1392 1393 1394 1395 1396 1397 1398 1399 1400 1401 1402 1403 1404 1405 1406 1407 1408 1409 1410 ... 1564